NTPO
Based on 1 Customer Validation
NTPO (Nitrilotris methylenephosphonic acid) is a DNA damage inducer, causing genomic DNA damage and fragmentation, activating ATR-mediated cell cycle checkpoints. The DNA damaging effects of NTPO are abrogated by base excision repair (BER) but not nucleotide excision repair (NER).
For research use only. We do not sell to patients.
- CAS No.: 6419-19-8
- Formula: C3H12NO9P3
- Molecular Weight:299.05
-
Storage:Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-B0302
Etidronic acid -
HY-11101
Alendronate sodium hydrateNitrogen-Containing Bisphosphonate -
HY-W008951
Ethylenediaminetetra(methylenephosphonic acid)Bone-targeting Ligand -
HY-W011500
TCEP hydrochlorideNon-Thiol Reducing Agent -
HY-W074006
Tris(2-cyanoethyl)phosphineProtein Crosslinker -
HY-W105694
3-Aminopropylphosphonic acidGABA Receptor Agonist -
HY-B0302A
Etidronic acid disodiumApoptosis Inducer -
HY-B0302R
Etidronic acid,60% in water (Standard) -
HY-15129
O-Phospho-L-serineEndogenous Metabolite -
HY-W008548
Di(adamantan-1-yl)phosphine -
HY-34477
2-IodoacetamideAlkylating Agent -
HY-13669
LomustineDNA Alkylator
Biological Activity
Description
Chemical Information
-
CAS No. 6419-19-8
-
Appearance Liquid (Density: 2.094±0.06 g/cm3)
-
Molecular Weight 299.05
-
Formula C3H12NO9P3
-
Color Colorless to light yellow
-
SMILES
OP(CN(CP(O)(O)=O)CP(O)(O)=O)(O)=O
-
Synonyms
Nitrilotris(methylenephosphonic acid)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
DMSO : 100 mg/mL (334.39 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (8.36 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (8.36 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocols
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Protocol for Southern Blot
Southern blot is a DNA hybridization assay used to detect a defined DNA sequence within restriction-digested or otherwise fragmented genomic DNA. The method separates DNA fragments by agarose gel electrophoresis, transfers the size-resolved DNA pattern onto a solid support, denatures the DNA to permit base pairing, and detects fragments that hybridize with a complementary labeled probe; the readout is a band, smear, or fragment-size distribution corresponding to the target sequence and its restriction-fragment context. The assay reflects sequence presence, restriction fragment length, gene copy pattern, structural rearrangement, insertion or deletion affecting restriction sites, and some repeat-length or terminal restriction fragment applications when the experimental design links the probe to those genomic features. Classic applications include Southern blot-based telomere terminal restriction fragment analysis and minisatellite-based DNA fingerprinting, which illustrate how the same
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (415 KB)
- English - EN (415 KB)
- Français - FR (415 KB)
- Deutsch - DE (415 KB)
- Norwegian - NO (415 KB)
- Español - ES (415 KB)
- Swedish - SV (415 KB)
- Italian - IT (415 KB)
- Korean - KR (415 KB)
- Portuguese - PT (415 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.3439 mL | 16.7196 mL | 33.4392 mL | 83.5981 mL |
| 5 mM | 0.6688 mL | 3.3439 mL | 6.6878 mL | 16.7196 mL | |
| 10 mM | 0.3344 mL | 1.6720 mL | 3.3439 mL | 8.3598 mL | |
| 15 mM | 0.2229 mL | 1.1146 mL | 2.2293 mL | 5.5732 mL | |
| 20 mM | 0.1672 mL | 0.8360 mL | 1.6720 mL | 4.1799 mL | |
| 25 mM | 0.1338 mL | 0.6688 mL | 1.3376 mL | 3.3439 mL | |
| 30 mM | 0.1115 mL | 0.5573 mL | 1.1146 mL | 2.7866 mL | |
| 40 mM | 0.0836 mL | 0.4180 mL | 0.8360 mL | 2.0900 mL | |
| 50 mM | 0.0669 mL | 0.3344 mL | 0.6688 mL | 1.6720 mL | |
| 60 mM | 0.0557 mL | 0.2787 mL | 0.5573 mL | 1.3933 mL | |
| 80 mM | 0.0418 mL | 0.2090 mL | 0.4180 mL | 1.0450 mL | |
| 100 mM | 0.0334 mL | 0.1672 mL | 0.3344 mL | 0.8360 mL |
NTPO Related Classifications
HY-W011425 Related Classifications
Powered by Bioz